BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kawai T, Elliott KJ, Scalia R, Eguchi S. Contribution of ADAM17 and related ADAMs in cardiovascular diseases. Cell Mol Life Sci 2021;78:4161-87. [PMID: 33575814 DOI: 10.1007/s00018-021-03779-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Almengló C, Couselo-Seijas M, Agra RM, Varela-Román A, García-Acuña JM, González-Peteiro M, González-Juanatey JR, Eiras S, Álvarez E. Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value. J Mol Med (Berl) 2021;99:1741-53. [PMID: 34529122 DOI: 10.1007/s00109-021-02129-4] [Reference Citation Analysis]
2 Wu Y, Wang M, Xu J, Wei J, Yang H. Signature network-based survey of the effects of a traditional Chinese medicine on heart failure. J Ethnopharmacol 2022;283:114750. [PMID: 34662664 DOI: 10.1016/j.jep.2021.114750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Adu-Amankwaah J, Adzika GK, Adekunle AO, Ndzie Noah ML, Mprah R, Bushi A, Akhter N, Huang F, Xu Y, Adzraku SY, Nadeem I, Sun H. ADAM17, A Key Player of Cardiac Inflammation and Fibrosis in Heart Failure Development During Chronic Catecholamine Stress. Front Cell Dev Biol 2021;9:732952. [PMID: 34966735 DOI: 10.3389/fcell.2021.732952] [Reference Citation Analysis]
4 Cicalese SM, da Silva JF, Priviero F, Webb RC, Eguchi S, Tostes RC. Vascular Stress Signaling in Hypertension. Circ Res 2021;128:969-92. [PMID: 33793333 DOI: 10.1161/CIRCRESAHA.121.318053] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Aimo A, Iborra-Egea O, Martini N, Galvez-Monton C, Burchielli S, Panichella G, Passino C, Emdin M, Bayes-Genis A. Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis. Sci Rep 2022;12:4691. [PMID: 35304529 DOI: 10.1038/s41598-022-08523-3] [Reference Citation Analysis]
6 Spaide RF. Treatment of Sorsby fundus dystrophy with anti-tumor necrosis factor-alpha medication. Eye (Lond) 2021. [PMID: 34376817 DOI: 10.1038/s41433-021-01735-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Erol A. Importance of Efferocytosis in COVID-19 Mortality. IDR 2022;Volume 15:995-1007. [DOI: 10.2147/idr.s348639] [Reference Citation Analysis]
8 Tang BY, Ge J, Wu Y, Wen J, Tang XH. The Role of ADAM17 in Inflammation-Related Atherosclerosis. J Cardiovasc Transl Res 2022. [PMID: 35648358 DOI: 10.1007/s12265-022-10275-4] [Reference Citation Analysis]
9 Savoia C, Volpe M, Kreutz R. Hypertension, a Moving Target in COVID-19: Current Views and Perspectives. Circ Res 2021;128:1062-79. [PMID: 33793331 DOI: 10.1161/CIRCRESAHA.121.318054] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
10 Guan C, Zhang HF, Wang YJ, Chen ZT, Deng BQ, Qiu Q, Chen SX, Wu MX, Chen YX, Wang JF. The Downregulation of ADAM17 Exerts Protective Effects against Cardiac Fibrosis by Regulating Endoplasmic Reticulum Stress and Mitophagy. Oxid Med Cell Longev 2021;2021:5572088. [PMID: 34035876 DOI: 10.1155/2021/5572088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]